# The role of the ubiquitin proteasome system in cerebellar development and medulloblastoma

**Authors:** Jerry Vriend, Saeid Ghavami, Hassan Marzban

PMC · DOI: 10.1186/s13041-015-0155-5 · 2015-10-17

## TL;DR

This paper explores how the ubiquitin proteasome system influences cerebellar development and the formation of medulloblastoma, a type of childhood brain tumor.

## Contribution

The paper proposes a novel hypothesis that proteasome dysfunction may drive medulloblastoma by disrupting granule cell differentiation.

## Key findings

- Proteasome dysfunction during development may lead to abnormal granule cell differentiation and medulloblastoma.
- Ubiquitin ligases like β-TrCP, FBW7, Huwe1, and SKP2 play roles in medulloblastoma initiation and progression.
- Dysfunction in proteasome activity could explain mutations in DNA repair mechanisms seen in medulloblastoma.

## Abstract

Cerebellar granule cells precursors are derived from the upper rhombic lip and migrate tangentially independent of glia along the subpial stream pathway to form the external germinal zone. Postnatally, granule cells migrate from the external germinal zone radially through the Purkinje cell layer, guided by Bergmann glia fibers, to the internal granular cell layer.

Medulloblastomas (MBs) are the most common malignant childhood brain tumor. Many of these tumors develop from precursor cells of the embryonic rhombic lips. Four main groups of MB are recognized. The WNT group of MBs arise primarily from the lower rhombic lip and embryonic brainstem. The SHH group of MBs originate from cerebellar granule cell precursors in the external germinal zone of the embryonic cerebellum. The cellular origins of type 3 and type 4 MBs are not clear.

Several ubiquitin ligases are revealed to be significant factors in development of the cerebellum as well as in the initiation and maintenance of MBs. Proteasome dysfunction at a critical stage of development may be a major factor in determining whether progenitor cells which are destined to become granule cells differentiate normally or become MB cells. We propose the hypothesis that proteasomal activity is essential to regulate the critical transition between proliferating granule cells and differentiated granule cells and that proteasome dysfunction may lead to MB. Proteasome dysfunction could also account for various mutations in MBs resulting from deficiencies in DNA checkpoint and repair mechanisms prior to development of MBs.

Data showing a role for the ubiquitin ligases β-TrCP, FBW7, Huwe1, and SKP2 in MBs suggest the possibility of a classification of MBs based on the expression (over expression or under expression) of specific ubiquitin ligases which function as oncogenes, tumor suppressors or cell cycle regulators.

## Linked entities

- **Genes:** BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase) [NCBI Gene 8945], FBXW7 (F-box and WD repeat domain containing 7) [NCBI Gene 55294], HUWE1 (HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1) [NCBI Gene 10075], SKP2 (S-phase kinase associated protein 2) [NCBI Gene 6502]
- **Diseases:** medulloblastoma (MONDO:0002794)

## Full-text entities

- **Genes:** KLF5 (KLF transcription factor 5) [NCBI Gene 688] {aka BTEB2, CKLF, IKLF}, Tbr1 (T-box brain transcription factor 1) [NCBI Gene 21375], Syvn1 (synovial apoptosis inhibitor 1, synoviolin) [NCBI Gene 74126] {aka 1200010C09Rik, D530017H19Rik, Hrd1}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, Itpr3 (inositol 1,4,5-triphosphate receptor 3) [NCBI Gene 16440] {aka IP3R 3, IP3R-3, Ip3r3, Itpr-3, tf}, Csnk1d (casein kinase 1, delta) [NCBI Gene 104318] {aka 1200006A05Rik, D930010H05Rik}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, Bmp2 (bone morphogenetic protein 2) [NCBI Gene 12156] {aka Bmp2a}, Lmx1a (LIM homeobox transcription factor 1 alpha) [NCBI Gene 110648] {aka Lmx1.1, dr, dreher, sst}, Neurod1 (neurogenic differentiation 1) [NCBI Gene 18012] {aka BETA2, BHF-1, Nd1, Neurod, bHLHa3}, Pax6 (paired box 6) [NCBI Gene 18508] {aka 1500038E17Rik, AEY11, Dey, Gsfaey11, Pax-6, Sey}, Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, Emi1 (proviral insertion Emi 1) [NCBI Gene 104323] {aka Emi-1}, Ctnnb1 (catenin beta 1) [NCBI Gene 84353] {aka Catnb}, Atoh1 (atonal bHLH transcription factor 1) [NCBI Gene 11921] {aka Hath1, MATH-1, Math1, bHLHa14}, Adora1 (adenosine A1 receptor) [NCBI Gene 11539] {aka A1-AR, A1AR, A1R, AA1R, ARA1, Ri}, Notch1 (notch 1) [NCBI Gene 18128] {aka 9930111A19Rik, Mis6, N1, Tan1, lin-12}, Gli3 (GLI-Kruppel family member GLI3) [NCBI Gene 14634] {aka Bph, GLI3-190, GLI3FL, Pdn, Xt, add}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Mxd1 (MAX dimerization protein 1) [NCBI Gene 17119] {aka Mad, Mad1}, Bcl2l11 (Bcl2-like 11) [NCBI Gene 64547] {aka Bim, BimL, Bod}, Mycn (MYCN proto-oncogene, bHLH transcription factor) [NCBI Gene 298894] {aka N-myc, Nmuc1, Nmyc}, FBXO5 (F-box protein 5) [NCBI Gene 26271] {aka EMI1, FBX5, Fbxo31}, DCTN6 (dynactin subunit 6) [NCBI Gene 10671] {aka WS-3, WS3, p27}, Shh (sonic hedgehog signaling molecule) [NCBI Gene 29499] {aka ShhNC}, Wnt1 (wingless-type MMTV integration site family, member 1) [NCBI Gene 22408] {aka Int-1, Wnt-1, sw, swaying}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, Iap1-3 (intracisternal A particle, Eya1 linked) [NCBI Gene 15601] {aka IAP}, Mcl1 (myeloid cell leukemia sequence 1) [NCBI Gene 17210] {aka Gm52627, Mcl-1}, MCL1 (MCL1 apoptosis regulator, BCL2 family member) [NCBI Gene 4170] {aka BCL2L3, EAT, MCL1-ES, MCL1L, MCL1S, Mcl-1}, Smurf2 (SMAD specific E3 ubiquitin protein ligase 2) [NCBI Gene 303614] {aka RGD1310067}, Sufu (SUFU negative regulator of hedgehog signaling) [NCBI Gene 361769], Wls (wntless WNT ligand secretion mediator) [NCBI Gene 68151] {aka 5031439A09Rik, EVI, Gpr177}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, Wnt2 (Wnt family member 2) [NCBI Gene 114487] {aka Wnt}, Fbxw7 (F-box and WD-40 domain protein 7) [NCBI Gene 50754] {aka 1110001A17Rik, AGO, Cdc4, Fbw7, Fbwd6, Fbx30}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 10891] {aka LEM6, PGC-1(alpha), PGC-1alpha, PGC-1v, PGC1, PGC1A}, Mef2d (myocyte enhancer factor 2D) [NCBI Gene 81518], Ret (ret proto-oncogene) [NCBI Gene 19713] {aka PTC, RET51, RET9, c-Ret}, Btrc (beta-transducin repeat containing protein) [NCBI Gene 12234] {aka Beta-Trcp1, E3RS-IkappaB, E3RSIkappaB, FWD1, Fbw1a, HOS}, Hgf (hepatocyte growth factor) [NCBI Gene 24446] {aka HPTA}, Ccnd2 (cyclin D2) [NCBI Gene 64033], TGIF1 (TGFB induced factor homeobox 1) [NCBI Gene 7050] {aka HPE4, TGIF}, Adgrg2 (adhesion G protein-coupled receptor G2) [NCBI Gene 237175] {aka B830041D06Rik, Gpr64, Me6}, Smo (smoothened, frizzled class receptor) [NCBI Gene 319757] {aka E130215L21Rik, Smoh, bnb, smoothened}, Mad2l1 (MAD2 mitotic arrest deficient-like 1) [NCBI Gene 56150] {aka MAD2}, Gast (gastrin) [NCBI Gene 14459] {aka GAS}, Mxd3 (Max dimerization protein 3) [NCBI Gene 17121] {aka 4631412E13Rik, Mad3, bHLHc13}, Shh (sonic hedgehog) [NCBI Gene 20423] {aka 9530036O11Rik, Dsh, HHG-1, Hhg1, Hx, Hxl3}, BTRC (beta-transducin repeat containing E3 ubiquitin protein ligase) [NCBI Gene 8945] {aka BETA-TRCP, FBW1A, FBXW1, FBXW1A, FWD1, bTrCP}, Bmp4 (bone morphogenetic protein 4) [NCBI Gene 12159] {aka Bmp-4, Bmp2b, Bmp2b-1, Bmp2b1}, GLI2 (GLI family zinc finger 2) [NCBI Gene 2736] {aka CJS, HPE9, PHS2, THP1, THP2}, ATOH1 (atonal bHLH transcription factor 1) [NCBI Gene 474] {aka ATH1, DFNA89, HATH1, MATH-1, bHLHa14}, Eomes (eomesodermin) [NCBI Gene 13813] {aka TBR-2, Tbr2}, Smo (smoothened, frizzled class receptor) [NCBI Gene 25273] {aka Smoh}, Srebf1 (sterol regulatory element binding transcription factor 1) [NCBI Gene 20787] {aka ADD1, SREBP1, bHLHd1}, Rbx1 (ring-box 1) [NCBI Gene 300084], Mtnr1a (melatonin receptor 1A) [NCBI Gene 17773] {aka MR, MelR}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, Ccnb1 (cyclin B1) [NCBI Gene 268697] {aka Ccnb1-rs1, Ccnb1-rs13, CycB1, Cycb-4, Cycb-5, Cycb1-rs1}
- **Diseases:** brain tumor (MESH:D001932), tumor suppressor (OMIM:601308), developmental disorders (MESH:D002658), Medulloblastoma (MESH:D008527), carcinogenesis (MESH:D063646), MB (OMIM:613675), neuroblastoma (MESH:D009447), type 3 and type 4 MBs (MESH:C536044), MB tumor (MESH:D009369), 3 tumors (MESH:C565335), midbrain and cerebellar defects (MESH:D020295), WNT tumors (MESH:D009371), colorectal cancer (MESH:D015179), SUFU (MESH:D000069337), B-cell lymphoma 2 (MESH:D016393), myeloid cell leukemia factor (MESH:D007951), acute lymphocytic leukemia (MESH:D054198), oncogenes (MESH:D000074723), mantle cell lymphoma (MESH:D020522), multiple myeloma (MESH:D009101)
- **Chemicals:** lactacystin (MESH:C067713), GABA (MESH:D005680), MG132 (MESH:C072553), Bortezomib (MESH:D000069286), potassium (MESH:D011188), T3 (MESH:D014284), Gamma-butyric acid (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus 1 (no rank) [taxon 11676], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090], Xenopus laevis (African clawed frog, species) [taxon 8355]
- **Cell lines:** NBP2 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_A628), HL60 leukemia — Homo sapiens (Human), Adult acute myeloid leukemia with maturation, Cancer cell line (CVCL_0002)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4609148/full.md

---
Source: https://tomesphere.com/paper/PMC4609148